Sertoli-leydig cell tumors
Other Names for this Disease
- Androblastoma of ovary
- Arrhenoblastoma of ovary
- Sertoli-leydig cell tumor of the ovary
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Because Sertoli-Leydig cell tumors of the ovary are rare, there are no established guidelines for treatment. Treatment decisions are based on the unique characteristics of each tumor, particularly the stage. Surgery to remove the tumor is considered the best treatment for an early-stage tumor, whereas surgery and chemotherapy may be needed to treat a later-stage tumor.
Last updated: 1/1/2013
- Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y, Guo L. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecologic Oncology. 2012; 127:384-389. http://www.ncbi.nlm.nih.gov/pubmed/22850410. Accessed 1/1/2013.
- Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M, Mangili G. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Gynecologic Oncology. 2012; 125:673-676. http://www.ncbi.nlm.nih.gov/pubmed/22446621. Accessed 1/1/2013.
- Finding Treatment Information - A video developed by GARD Information Specialists that explains how you can find information about treatment for a rare disease.
- ClinicalTrials.gov lists trials that are studying or have studied Sertoli-leydig cell tumors. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.